PKAN pathogenesis and treatment

Susan J. Hayflick*, Suh Young Jeong, Ody C.M. Sibon

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)
58 Downloads (Pure)


Studies aimed at supporting different treatment approaches for pantothenate kinase-associated neurodegeneration (PKAN) have revealed the complexity of coenzyme A (CoA) metabolism and the limits of our current knowledge about disease pathogenesis. Here we offer a foundation for critically evaluating the myriad approaches, argue for the importance of unbiased disease models, and highlight some of the outstanding questions that are central to our understanding and treating PKAN.

Original languageEnglish
Pages (from-to)283-291
Number of pages9
JournalMolecular Genetics and Metabolism
Issue number3
Publication statusPublished - Nov-2022


  • Brain iron
  • Coenzyme A
  • Mitochondrial acyl carrier protein
  • Pantothenate kinase
  • Phosphopantetheinylation
  • PKAN


Dive into the research topics of 'PKAN pathogenesis and treatment'. Together they form a unique fingerprint.

Cite this